Mark Erlander | executive |
James Levine | executive |
Marc Frahm | analyst |
Welcome to the Cardiff Oncology Second Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference call over to Kiki Patel of Gilmartin Group. Please go ahead.
Thank you, operator.
Joining us on the call today from Cartus Oncology, our Chief Executive Officer, Mark Erlander, and Chief Financial Officer, Jamie Levin.